AMRS Amyris, Inc. Stock Quote

AMRS [NASD]

Basic Materials | Specialty Chemicals | USA

Index	-	P/E	-	EPS (ttm)	-1.72	Insider Own	41.56%	Shs Outstand	246.82M	Perf Week	-20.33%
Market Cap	2.92B	Forward P/E	-	EPS next Y	-0.27	Insider Trans	-4.23%	Shs Float	154.20M	Perf Month	-31.04%
Income	-382.30M	PEG	-	EPS next Q	-0.03	Inst Own	39.70%	Short Float	16.87%	Perf Quarter	-14.24%
Sales	173.10M	P/S	16.86	EPS this Y	29.60%	Inst Trans	7.78%	Short Ratio	5.39	Perf Half Y	437.09%
Book/sh	-0.72	P/B	-	EPS next Y	-100.00%	ROA	-177.00%	Target Price	-	Perf Year	326.87%
Cash/sh	0.12	P/C	96.66	EPS next 5Y	30.00%	ROE	297.50%	52W Range	1.88 - 23.42	Perf YTD	85.26%
Dividend	-	P/FCF	-	EPS past 5Y	40.80%	ROI	-269.30%	52W High	-51.15%	Beta	1.13
Dividend %	-	Quick Ratio	0.60	Sales past 5Y	38.40%	Gross Margin	49.30%	52W Low	510.13%	ATR	1.25
Employees	595	Current Ratio	0.90	Sales Q/Q	96.80%	Oper. Margin	-	RSI (14)	31.52	Volatility	12.44% 7.84%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	25.20%	Profit Margin	-	Rel Volume	0.65	Prev Close	12.22
Shortable	Yes	LT Debt/Eq	-	Earnings	May 06 BMO	Payout	-	Avg Volume	4.83M	Price	11.44
Recom	1.60	SMA20	-22.09%	SMA50	-33.16%	SMA200	38.10%	Volume	3,148,081	Change	-6.38%

Mar-03-21

Reiterated

H.C. Wainwright

Buy

$11 → $35

Feb-26-21

Initiated

ROTH Capital

Buy

$20

Jan-06-21

Upgrade

Cowen

Market Perform → Outperform

Nov-25-20

Initiated

Jefferies

Buy

$3.35

Nov-25-20

Initiated

Cowen

Market Perform

Dec-12-19

Initiated

Oppenheimer

Outperform

Nov-14-18

Reiterated

B. Riley FBR

Buy

$10 → $8

Jan-25-18

Initiated

B. Riley FBR, Inc.

Buy

May-28-14

Resumed

Stifel

Hold

Feb-10-12

Downgrade

Deutsche Bank

Buy → Hold

$20 → $9

Nov-02-11

Downgrade

Robert W. Baird

Outperform → Neutral

$25 → $16

Jan-28-11

Downgrade

Stifel Nicolaus

Buy → Hold

Nov-08-10

Initiated

Stifel Nicolaus

Buy

$22

May-07-21 01:01AM	Amyris Inc (AMRS) Q1 2021 Earnings Call Transcript Motley Fool +7.10%
May-06-21 09:25AM	Amyris, Inc. (AMRS) Reports Q1 Loss, Tops Revenue Estimates Zacks -16.16%
08:00AM	Amyris, Inc. Reports First Quarter 2021 Financial Results PR Newswire
May-05-21 08:00AM	Amyris Brand Pipette Partners With Baby2baby To Help Babies And Families In Need PR Newswire -6.52%
07:07AM	Amyris (AMRS) to Report Q1 Earnings: What's in the Offing? Zacks
May-03-21 03:36PM	Amyris and Ingredion Partner to Manufacture and Market Sugar Reduction and Fermentation-Based Food Ingredients GlobeNewswire
03:23PM	Amyris And Ingredion Partner To Manufacture And Market Sugar Reduction And Fermentation-based Food Ingredients PR Newswire
Apr-30-21 05:50PM	Amyris, Inc. (AMRS) Dips More Than Broader Markets: What You Should Know Zacks
Apr-29-21 05:06PM	Amyris, Inc. (AMRS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-26-21 08:00AM	Amyris Hosts Successful Final Session Of Its Three-Part Virtual Mini-Series PR Newswire
Apr-21-21 08:00AM	Amyris To Host First Quarter 2021 Financial Results Conference Call On May 6 PR Newswire
Apr-15-21 08:00AM	Amyris To Acquire EcoFabulous Clean Beauty Brand Focused On Fast-Growing Gen Z Consumer Segment PR Newswire
Apr-14-21 08:00AM	Amyris To Acquire Beauty Labs Combining Clean Beauty Leadership With Digital Innovation PR Newswire
Apr-09-21 06:00AM	Amyris Announces Pricing of a $300.0 Million Public Offering (Secondary and Primary) of Common Stock PR Newswire
Apr-07-21 05:45PM	Amyris Announces Proposed Public Offering (Secondary And Primary) Of Common Stock PR Newswire -7.46%
08:00AM	Amyris Brand Biossance® partners With Reese Witherspoon To Accelerate Clean Beauty Movement PR Newswire
Apr-05-21 04:05PM	Amyris to Present at Cowen's 2nd Annual Consumer Platforms for the Next Generation Summit on April 6, 2021 PR Newswire -7.69%
Apr-01-21 08:00AM	Amyris To Host Third Webinar In Its Virtual Investor Mini-Series PR Newswire
Mar-31-21 08:00AM	Amyris And DSM Close Significant Strategic Transaction To Accelerate The Growth Of Natural, Sustainable Ingredients PR Newswire
Mar-30-21 12:01PM	Top Marijuana Stocks on the NASDAQ for April 2021 Investopedia +7.00%
Mar-29-21 04:58PM	Top Marijuana Stocks for April 2021 Investopedia
Mar-25-21 08:00AM	Amyris Delivers Record Production Of CBG For Consumer Skincare Formulations PR Newswire +5.97%
Mar-16-21 08:00AM	Amyris Enters Partnership With Minerva Foods For Zero Carbon Protein Production PR Newswire
Mar-14-21 01:16PM	3 Monster Growth Stocks That Could Reach New Highs TipRanks
Mar-12-21 10:50PM	AMYRIS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amyris, Inc. - AMRS Business Wire +14.59%
Mar-10-21 08:00AM	Amyris To Present At The Virtual 33rd Annual Roth Conference On March 17, 2021 PR Newswire -7.84%
Mar-09-21 08:00AM	Amyris Consumer Brand Purecane Named To Fast Company's Annual List Of World's Most Innovative Companies For 2021 PR Newswire +12.12%
Mar-02-21 10:30PM	Amyris Inc (AMRS) Q4 2020 Earnings Call Transcript Motley Fool +27.39%
08:47AM	Amyris: Q4 Earnings Insights Benzinga
08:28AM	Amyris, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results PR Newswire
07:36AM	Amyris Jumps on Earnings Beat, 2021 Outlook TheStreet.com
07:15AM	Amyris, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-21 10:12AM	Amyris's Earnings: A Preview Benzinga +13.48%
08:00AM	Amyris Acquiring Costa Brazil Clean Beauty Brand - Francisco Costa To Join Amyris As Chief Creative Officer PR Newswire
Feb-26-21 10:50PM	AMYRIS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amyris, Inc. - AMRS PR Newswire
10:04AM	Benzinga's Top Ratings Upgrades, Downgrades For February 26, 2021 Benzinga
Feb-25-21 08:00AM	Amyris Announces Participation In Upcoming Investor Conferences PR Newswire -9.44%
Feb-24-21 08:00AM	Amyris Announces Launch of Pipette® Clean Baby Care Brand in Target Retail Stores Across North America PR Newswire
Feb-22-21 08:00AM	Amyris Announces Positive Pre-Clinical Results For COVID-19 RNA Vaccine Platform With Advantaged Manufacturing, Storage And Distribution Characteristics PR Newswire
Feb-17-21 08:00AM	Amyris To Host Fourth Quarter And Full Year 2020 Financial Results Conference Call On March 2 PR Newswire
Feb-10-21 08:00AM	Amyris Hosts Successful Second Session Of Its Virtual Investor Mini-Series PR Newswire +6.46%
Feb-03-21 08:00AM	Amyris to Host Second Webinar in its Virtual Investor Mini-Series PR Newswire +21.05%
Feb-02-21 08:00AM	Amyris Announces Breakthrough Clinical Results For Its Clean Formulation Acne Treatment PR Newswire
Jan-22-21 10:50PM	AMYRIS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amyris, Inc. - AMRS Business Wire
08:00AM	Amyris Acquiring Terasana Brand To Offer Clean Cannabinoid Consumer Products PR Newswire
Jan-15-21 08:00AM	Amyris Ranked Among World's Top Social And Environmental Impact Companies By Real Leaders® PR Newswire +8.04%
Jan-11-21 08:00AM	Amyris Creates Partnership With Jonathan Van Ness To Launch Leading Clean Haircare Brand PR Newswire +8.16%
Jan-04-21 08:00AM	Amyris To Launch Its Biossance TM Clean Beauty Brand In China Through Partnership With Superordinary PR Newswire +13.68%
Dec-28-20 08:00AM	Amyris Announces Bonsucro Certification Sustainable Sugarcane Production For Clean Ingredients PR Newswire +10.11%
Dec-24-20 08:52AM	Are Options Traders Betting on a Big Move in Amyris (AMRS) Stock? Zacks
Dec-21-20 09:30AM	SHAREHOLDER ALERT: Amyris, Inc. (NASDAQ: AMRS) Officers and Directors Under Investigation for Possible Breaches of Fiduciary Duty PR Newswire +10.98%
08:44AM	Amyris (AMRS) Surges: Stock Moves 7.1% Higher Zacks
08:00AM	Amyris Closes $50 Million Strategic Transaction PR Newswire
Dec-16-20 08:00AM	Amyris Hosts Successful First Session Of Its Virtual Investor Mini-Series PR Newswire +20.47%
Dec-11-20 10:34AM	Is AMRS A Good Stock To Buy Now? Insider Monkey +8.72%
Dec-08-20 09:00AM	Purecane, the Revolutionary Sweetener Derived from Sugarcane, Wins 2020 Popular Science Best of What's New Award PR Newswire
Dec-03-20 08:00AM	Amyris Launches Virtual Investor Mini-Series PR Newswire
Nov-30-20 08:00AM	Amyris Delivers Record Black Friday Sales PR Newswire
Nov-23-20 08:00AM	Amyris To Present at Evercore ISI's 3rd Annual HealthCONx Conference on December 3, 2020 PR Newswire +5.22%
Nov-18-20 10:23AM	New Strong Sell Stocks for November 18th Zacks
Nov-05-20 08:00AM	Amyris, Inc. Reports Third Quarter 2020 Financial Results PR Newswire -19.01%
Oct-30-20 08:00AM	Amyris And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand And Business Partnership PR Newswire -5.66%
Oct-26-20 11:00AM	INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors Business Wire -6.23%
Oct-23-20 07:06PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors Business Wire +7.02%
08:00AM	Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5 PR Newswire
Oct-22-20 08:00AM	Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine PR Newswire
Oct-20-20 09:30AM	Amyris and Arzeda Enter into Development Collaboration Agreement PR Newswire
Oct-09-20 09:00AM	Kaskela Law LLC Announces Stockholder Investigation of Amyris, Inc. (AMRS) and Encourages Long-Term Investors to Contact the Firm PR Newswire
Oct-08-20 09:00AM	The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors Business Wire
Oct-07-20 09:22AM	Why Amyris Fell 11% in September Motley Fool
Oct-01-20 08:30AM	Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed PR Newswire +6.51%
Sep-22-20 07:00PM	Media Advisory - Canfor Corporation and Canfor Pulp Products Inc. Announce Third Quarter Results Conference Call CNW Group
Sep-21-20 08:30AM	Amyris' Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles' Day Sales PR Newswire
Sep-15-20 08:30AM	Amyris Continues Market Adoption Of Its Sweetener With Approval By Health Canada PR Newswire +8.26%
Sep-14-20 07:00AM	Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today PR Newswire
Sep-11-20 04:22PM	Why Amyris Shares Dropped 26% Today Motley Fool -25.80%
03:25PM	Amyris Denies 'Patent Infringement' Allegations On Heels Of $881M Lavvan Lawsuit Benzinga
05:00AM	Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020 PR Newswire
Sep-10-20 03:41PM	LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc. For Patent Infringement and Trade Secret Misappropriation PR Newswire
Sep-08-20 08:30AM	Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 PR Newswire
Sep-04-20 08:50AM	New Strong Sell Stocks for September 4th Zacks -6.44%
Sep-01-20 03:30PM	Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential TipRanks
08:30AM	Amyris Scales First Fermentation-Based Cannabinoid PR Newswire
08:30AM	Amyris Scales First Fermentation-Based Cannabinoid CNW Group
Aug-20-20 08:31AM	Should Amyris Split Into 2 Companies? Motley Fool
Aug-14-20 08:30AM	Amyris Appoints Sheila Shekar Pollak As Chief Marketing Officer Of Biossance PR Newswire -5.50%
Aug-06-20 08:30AM	Amyris, Inc. Reports Second Quarter 2020 Results PR Newswire -18.32%
Jul-29-20 05:01PM	Rigrodsky & Long, P.A. Files Class Action Suit Against Amyris, Inc. GlobeNewswire
12:25PM	INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Amyris, Inc. - AMRS PR Newswire
Jul-28-20 09:07PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Amyris, Inc. PR Newswire
Jul-27-20 12:41PM	Here's Why Amyris Stock Rose as Much as 12.2% Today Motley Fool +6.57%
08:30AM	Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application PR Newswire
Jul-23-20 08:30AM	Amyris To Host Second Quarter 2020 Financial Results Conference Call On August 6 PR Newswire
Jul-20-20 01:29PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
01:20PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
09:53AM	INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ:AMRS) ACCESSWIRE
Jul-18-20 11:16AM	INVESTIGATION ALERT: Labaton Sucharow is Investigating Amyris, Inc. for Potential Securities Violations and Breach of Fiduciary Duty (NASDAQ:AMRS) ACCESSWIRE
Jul-17-20 12:40PM	SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Jul-16-20 07:25PM	ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
06:31PM	INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Amyris, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm Business Wire

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kung Frank	Director	Apr 14	Option Exercise	4.76	1,212,787	5,772,866	6,796,205	Apr 15 07:58 PM
Kung Frank	Director	Apr 13	Option Exercise	4.26	1,943,659	8,279,987	8,463,618	Apr 15 07:58 PM
Kung Frank	Director	Apr 13	Sale	14.96	4,678,363	70,000,006	711,258	Apr 15 07:58 PM
DOERR L JOHN	Director	Dec 11	Option Exercise	2.87	5,000,000	14,350,000	70,156,794	Dec 15 07:18 PM
Kung Frank	Director	Jun 05	Buy	3.00	3,689,225	11,067,675	6,284,876	Jun 09 09:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience